BridgeMD
New treatment option for Healthy Participants
Official title Study of the Correlation Between Cortical Excitability and Cytoarchitectonics of Prefrontal Cortex in Healthy Adult Participants, Using Transcranial Magnetic Stimulation Coupled to EEG and High-field MRI
ClinicalTrials.gov ID: NCT07071259
What this study is testing
- What it's testing
- Repeated transcranial magnetic stimulation (rTMS) is mainly used to treat mood disorders by addressing differences in brain function, particularly in the dorsolateral prefrontal cortex (DLPFC), which affects emotions and executive functions. The therapy aims to enhance the left DLPFC or suppress the right.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35. Healthy volunteers may be eligible.
You may be able to join if
- People aged 18 to 35
- People affiliated with a social security scheme or beneficiary of such a scheme
- People who have signed the informed consent
- Right-handed people
- People with a body mass index between 18 and 26
You likely can't join if
- Pregnant, parturient, or breastfeeding
- Protected adults
- Minors
- People staying in a healthcare or social institution
- People in an emergency situation
- People deprived of their liberty
See the full eligibility criteria
- People aged 18 to 35
- People affiliated with a social security scheme or beneficiary of such a scheme
- People who have signed the informed consent
- Right-handed people
- People with a body mass index between 18 and 26
- People able to abstain from alcohol for 24 hours prior to the experiment
- People able to remain perfectly still for 15 minutes straight, and able to have reduced mobility for 3 hours
- People able to of not using narcotics (marijuana, cocaine, ecstasy, MDMA, ketamine, etc.) during the 15 days preceeding the experiment.
- Conducting a pregnancy test before inclusion for women of childbearing age and when the research is conducted over a long period, at a frequency adapted to the gaze of the research acts
- Effective contraception for women of childbearing potential
- Pregnant, parturient, or breastfeeding
- Protected adults
- Minors
- People staying in a healthcare or social institution
- People in an emergency situation
- People deprived of their liberty
- People with the usual contraindications to MRI
- Ferromagnetic surgical clips, ocular implants, metallic foreign bodies intraocularly or in the nervous system, implants or metallic objects susceptible to concentrate the radio frequency field, cochlear implants, brain...
- Claustrophobia
- Large, black tattoo close to the orofacial area
- People not wishing to be informed of abnormalities discovered at the MRI
- People with a history of epilepsy or suffering from epilepsy
- Individuals whose parents, children, siblings, or parents have a history of epilepsy
- People with known neurological and/or psychiatric disorders with past and/or current medical treatment, or drug addiction
- Staff with a hierarchical link to the investigators
The study team makes the final eligibility decision.
Where it's taking place
- Marseille, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Marseille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.